Cleared Traditional

K890619 - EDL ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENT

K890619 is an FDA 510(k) clearance for EDL ACTIVATED PARTIAL THROMBOPLASTIN TI..., manufactured by Elite Diagnostic , Ltd.. The device is a Class 2 Hematology device with product code GFO cleared through the Traditional 510(k) pathway after a 36-day FDA review.

K890619 · Elite Diagnostic , Ltd. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1989
Decision
36d
Days
Class 2
Risk

K890619 is an FDA 510(k) clearance for the EDL ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENT. Classified as Activated Partial Thromboplastin (product code GFO), Class II - Special Controls.

Submitted by Elite Diagnostic , Ltd. (Indianapolis, US). The FDA issued a Cleared decision on March 15, 1989 after a review of 36 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7925 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Elite Diagnostic , Ltd. devices

FDA 510(k) Submission Details - K890619

510(k) Number K890619 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 07, 1989
Decision Date March 15, 1989
Days to Decision 36 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
77d faster than avg
Panel avg: 113d · This submission: 36d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GFO Device Classification - Class 2, Special Controls

Product Code GFO Activated Partial Thromboplastin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7925
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GFO Activated Partial Thromboplastin

All 44
Devices cleared under the same product code (GFO) and FDA review panel - the closest regulatory comparables to K890619.
ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
K896545 · Sigma Chemical Co. · Dec 1989
APTT-P REAGENT, A PARTICLE ACTIVATED REAGENT
K895255 · Medical Diagnostic Technologies, Inc. · Oct 1989
THROMBOSCREEN APTT REAGENT
K891337 · Pacific Hemostasis · Apr 1989
APTT REAGENT
K884856 · Precision Biologicals, Inc. · Jan 1989
EASY-TEST PARTIAL THROMBOPLASTIN TIME PTT #16629
K884702 · Em Diagnostic Systems, Inc. · Jan 1989
KD ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENT
K884485 · King Diagnostics, Inc. · Dec 1988